BCL2L1 and rheumatoid arthritis: Co-localization analysis further validated the association between methylation sites and RA, particularly for BCL2L1, RAF1, DNMT3B, ERRFI1, and NEK4, where we identified shared causal signals with RA (posterior probability of H4 > 0.5).